Biolog Device Statistics

Total Valuation

Biolog Device has a market cap or net worth of KRW 25.50 billion. The enterprise value is 26.06 billion.

Market Cap	25.50B
Enterprise Value	26.06B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Biolog Device has 65.90 million shares outstanding. The number of shares has increased by 34.94% in one year.

Current Share Class	n/a
Shares Outstanding	65.90M
Shares Change (YoY)	+34.94%
Shares Change (QoQ)	+4.47%
Owned by Insiders (%)	0.91%
Owned by Institutions (%)	n/a
Float	37.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.15
PB Ratio	0.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.91, with an EV/FCF ratio of -34.35.

EV / Earnings	-1.87
EV / Sales	0.18
EV / EBITDA	14.91
EV / EBIT	n/a
EV / FCF	-34.35

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.19.

Current Ratio	1.25
Quick Ratio	1.02
Debt / Equity	0.19
Debt / EBITDA	4.68
Debt / FCF	-13.55
Interest Coverage	-4.60

Financial Efficiency

Return on equity (ROE) is -20.02% and return on invested capital (ROIC) is -5.82%.

Return on Equity (ROE)	-20.02%
Return on Assets (ROA)	-4.51%
Return on Capital (ROIC)	-5.82%
Revenue Per Employee	3.85B
Profits Per Employee	-376.76M
Employee Count	37
Asset Turnover	1.72
Inventory Turnover	26.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-56.12%
50-Day Moving Average	464.00
200-Day Moving Average	589.89
Relative Strength Index (RSI)	21.86
Average Volume (20 Days)	86,602

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biolog Device had revenue of KRW 142.35 billion and -13.94 billion in losses. Loss per share was -244.59.

Revenue	142.35B
Gross Profit	4.63B
Operating Income	-5.98B
Pretax Income	-8.95B
Net Income	-13.94B
EBITDA	2.20B
EBIT	-5.98B
Loss Per Share	-244.59

Full Income Statement

Balance Sheet

The company has 6.58 billion in cash and 10.28 billion in debt, giving a net cash position of -3.70 billion or -56.16 per share.

Cash & Cash Equivalents	6.58B
Total Debt	10.28B
Net Cash	-3.70B
Net Cash Per Share	-56.16
Equity (Book Value)	53.87B
Book Value Per Share	910.73
Working Capital	7.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.74 billion and capital expenditures -3.50 billion, giving a free cash flow of -758.74 million.

Operating Cash Flow	2.74B
Capital Expenditures	-3.50B
Free Cash Flow	-758.74M
FCF Per Share	-11.51

Full Cash Flow Statement

Margins

Gross margin is 3.25%, with operating and profit margins of -4.20% and -9.79%.

Gross Margin	3.25%
Operating Margin	-4.20%
Pretax Margin	-6.28%
Profit Margin	-9.79%
EBITDA Margin	1.54%
EBIT Margin	-4.20%
FCF Margin	-0.53%

Dividends & Yields

Biolog Device does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.94%
Shareholder Yield	-34.94%
Earnings Yield	-63.20%
FCF Yield	-2.98%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biolog Device has an Altman Z-Score of 2.43. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.43
Piotroski F-Score	n/a